RZB is efficacious in reducing signs and symptoms of PsA in patients, regardless of patterns of joint involvement Abs 1504 #ACR @AlexisOgdie @RheumNow
Efficacy of Risankizumab in the Treatment of PsA Patients with Limited and Extensive Joint Involvement - ACR Meeting Abstracts
